tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
US Market

Akebia Therapeutics (AKBA) Income Statement

Compare
1,628 Followers

Akebia Therapeutics Income Statement

Last quarter (Q4 2025), Akebia Therapeutics's total revenue was $57.62M, an increase of 23.92% from the same quarter last year. In Q4, Akebia Therapeutics's net income was $-12.24M. See Akebia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 236.20M$ 160.18M$ 194.62M$ 292.48M$ 211.65M
Gross Profit
$ 196.73M$ 97.00M$ 120.47M$ 269.99M$ 130.16M
Operating Expenses
$ 173.24M$ 147.47M$ 166.73M$ 350.77M$ 394.66M
Depreciation and Amortization
$ 1.27M$ 37.50M$ 37.63M$ 37.70M$ 37.97M
EBITDA
$ 21.73M$ -13.72M$ -8.27M$ 3.06M$ -189.91M
Operating Income
$ 23.50M$ -50.47M$ -46.26M$ -80.78M$ -264.50M
Other Income/Expenses
$ -27.22M$ -18.94M$ -5.67M$ -13.45M$ -17.52M
Pretax Income
$ -3.72M$ -69.41M$ -51.92M$ -94.23M$ -282.02M
Net Income
$ -5.34M$ -69.41M$ -51.92M$ -94.23M$ -282.02M
Per Share Metrics
Basic EPS
$ -0.02$ -0.33$ -0.28$ -0.58$ -1.48
Diluted EPS
$ -0.02$ -0.33$ -0.28$ -0.58$ -1.48
Weighted Average Shares Outstanding
257.16M 210.95M 187.47M 182.78M 165.95M
Weighted Average Shares Outstanding (Diluted)
257.16M 210.95M 187.47M 182.78M 165.95M
Currency in USD

Akebia Therapeutics Earnings and Revenue History